Mirador Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$250M
- Investors
-
17
Mirador Therapeutics General Information
Description
Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. The company offers features such as a proprietary data analytics engine that harmonizes extensive patient molecular profiles, identifies novel therapeutic targets, and develops diagnostics, enabling researchers and healthcare providers to create targeted therapies based on individual genetics, ultimately improving treatment outcomes for patients suffering from chronic conditions.
Contact Information
Website
www.miradortx.comCorporate Office
- 4902 Headquarters Point
- Suite 300
- San Diego, CA 92121
- United States
Corporate Office
- 4902 Headquarters Point
- Suite 300
- San Diego, CA 92121
- United States
Mirador Therapeutics Timeline
Mirador Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 30-Sep-2025 | $250M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 21-Mar-2024 | Completed | Generating Revenue | |||
| 1. Seed Round | $85M | $85M | Completed | Generating Revenue |
Mirador Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed | 34,000,000 | $0.000100 | $2.5 | $2.5 | 1x | $2.5 | 11.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Mirador Therapeutics Comparisons
Industry
Financing
Details
Mirador Therapeutics Competitors (17)
One of Mirador Therapeutics’s 17 competitors is Kriya Therapeutics, a Venture Capital-Backed company based in Morrisville, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kriya Therapeutics | Venture Capital-Backed | Morrisville, NC | ||||
| Bright Peak Therapeutics | Venture Capital-Backed | Allschwil, Switzerland | ||||
| PrecisionLife | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Fibrocor Therapeutics | Venture Capital-Backed | Toronto, Canada | ||||
| Aulos | Venture Capital-Backed | Larkspur, CA |
Mirador Therapeutics Patents
Mirador Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136516-A2 | Osmr-binding antibodies | Pending | 19-Dec-2024 | ||
| WO-2026136516-A3 | Osmr-binding antibodies | Pending | 19-Dec-2024 | ||
| WO-2026060117-A1 | Bispecific antibodies binding to tl1a and osmr | Pending | 13-Sep-2024 | ||
| WO-2026011090-A1 | Methods, compositions, and kits for treatment of inflammatory diseases by targeting ripk2 | Pending | 03-Jul-2024 | ||
| US-20260091026-A1 | Methods of treating inflammatory diseases | Pending | 09-Jun-2023 | A61K31/437 |
Mirador Therapeutics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Blue Owl Capital | Asset Manager | Minority | ||
| Boxer Capital | Corporate Venture Capital | Minority | ||
| Fairmount Partners | Investment Bank | Minority |
Mirador Therapeutics Investments (1)
Mirador Therapeutics’s most recent deal was a PIPE with Jasper Therapeutics for . The deal was made on 16-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jasper Therapeutics | 16-Jul-2026 | PIPE | Biotechnology |
Mirador Therapeutics FAQs
-
When was Mirador Therapeutics founded?
Mirador Therapeutics was founded in 2024.
-
Where is Mirador Therapeutics headquartered?
Mirador Therapeutics is headquartered in San Diego, CA.
-
What industry is Mirador Therapeutics in?
Mirador Therapeutics’s primary industry is Biotechnology.
-
Is Mirador Therapeutics a private or public company?
Mirador Therapeutics is a Private company.
-
What is the current valuation of Mirador Therapeutics?
The current valuation of Mirador Therapeutics is .
-
What is Mirador Therapeutics’s current revenue?
The current revenue for Mirador Therapeutics is .
-
How much funding has Mirador Therapeutics raised over time?
Mirador Therapeutics has raised $735M.
-
Who are Mirador Therapeutics’s investors?
Alexandria Venture Investments, ARCH Venture Partners, Blue Owl Capital, Boxer Capital, and Fairmount Partners are 5 of 17 investors who have invested in Mirador Therapeutics.
-
Who are Mirador Therapeutics’s competitors?
Kriya Therapeutics, Bright Peak Therapeutics, PrecisionLife, Fibrocor Therapeutics, and Aulos are some of the 17 competitors of Mirador Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process